STEPSTONE GROUP LP
Q2 2022 Form 13-F
LA JOLLA, CALIFORNIA
CIK 0001502287
· CRD 143635
· SEC-registered investment adviser
$934.9M Reported Value Total
STEPSTONE GROUP LP reports 277 total accounts under management (AUM). There are 250 discretionary accounts valued at $72,253,048,283, and 27 non-discretionary accounts valued at $6,871,465,842.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
509 funds
· $126.5B gross asset value
Private Equity Fund: $117.7B · Venture Capital Fund: $8.8B · Real Estate Fund: $4.7M · Hedge Fund: $236
Source: Form ADV filed 2026-07-30
Reported value
$934.9M
Quarter over quarter
-30.5%
Holdings
27
Top-10 concentration
91.6%
Key People
Form ADV owners & control persons
Bendukai Edward Bouey
CHIEF COMPLIANCE OFFICER
Jose Agustin Fernandez
CO-CHIEF OPERATING OFFICER, PARTNER
Scott William Hart
PARTNER, CHIEF EXECUTIVE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q2 2022 13F record
Q2 2022 13F filing summary
| Period of report | June 30, 2022 |
|---|---|
| Filed | August 12, 2022 |
| Form | 13F-HR |
| Reported value | $934.9M |
| Positions | 27 |
| Change in reported value | -30.3% |
| New positions | 8 |
| Exited positions | 3 |
| Position turnover | 36.7% |
| Top-10 concentration | 91.6% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 13, 2026
|
23 | $2.2B |
|
Q1 2026 13F
Filed May 15, 2026
|
18 | $207.5M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
23 | $186.9M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
16 | $212.7M |
|
Q2 2025 13F
Filed Aug 13, 2025
|
14 | $50.4M |
|
Q1 2025 13F
Filed May 14, 2025
|
16 | $97.4M |
|
Q4 2024 13F
Filed Feb 13, 2025
|
14 | $114.4M |
|
Q3 2024 13F
Filed Nov 12, 2024
|
14 | $274.1M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
16 | $493.1M |
|
Q1 2024 13F
Filed May 13, 2024
|
21 | $471.6M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
22 | $555.6M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
22 | $448.9M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
24 | $540.8M |
|
Q1 2023 13F
Filed May 15, 2023
|
21 | $538.1M |
|
Q4 2022 13F
Filed Feb 10, 2023
|
24 | $766.5M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
30 | $703.1M |
|
Q2 2022 13F
Filed Aug 12, 2022
|
27 | $934.9M |
|
Q1 2022 13F
Filed May 13, 2022
|
22 | $1.3B |
|
Q4 2021 13F
Filed Feb 11, 2022
|
37 | $1.8B |
|
Q3 2021 13F
Filed Nov 12, 2021
|
23 | $1.5B |
33 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q2 2022
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | DNB DUN & BRADSTREET HLDGS INC | $331.3M | 35.44% |
| 2 | USER USERTESTING INC | $124.8M | 13.35% |
| 3 | WKME WALKME LTD | $105.0M | 11.23% |
| 4 | BHG BRIGHT HEALTH GROUP INC | $75.9M | 8.11% |
| 5 | XMTR XOMETRY INC | $72.9M | 7.8% |
| 6 | RKLBXXXX ROCKET LAB USA INC | $46.6M | 4.98% |
| 7 | PATH UIPATH INC | $32.5M | 3.48% |
| 8 | ML MONEYLION INC | $32.2M | 3.45% |
| 9 | NGM NGM BIOPHARMACEUTICALS INC | $20.2M | 2.16% |
| 10 | RBLX ROBLOX CORP | $15.4M | 1.64% |
| 11 | DOMA DOMA HOLDINGS INC | $15.3M | 1.64% |
| 12 | ROVR ROVER GROUP INC | $10.7M | 1.15% |
| 13 | VCSA VACASA INC | $8.5M | 0.91% |
| 14 | GROV GROVE COLLABORATIVE HOLD INC | $8.1M | 0.86% |
| 15 | TRDA ENTRADA THERAPEUTICS INC | $7.7M | 0.83% |
| 16 | HLVX HILLEVAX INC | $7.4M | 0.79% |
| 17 | IMGO IMAGO BIOSCIENCES INC | $7.0M | 0.75% |
| 18 | PL PLANET LABS PBC | $3.6M | 0.39% |
| 19 | PHAT PHATHOM PHARMACEUTICALS INC | $3.6M | 0.38% |
| 20 | TNYA TENAYA THERAPEUTICS INC | $2.6M | 0.28% |
Values as reported on the Q2 2022 Form 13F. Every position is in the holdings table below.